Skip to main content

View full-text article in PMC

. 2020 Sep 12;7(10):ofaa425. doi: 10.1093/ofid/ofaa425

Table 3. .

Associations Between sCD14 and Endothelial Activation Markers by HIV Status

		sICAM-1		sVCAM-1
		β (95% CI)	P _interaction ^a	β (95% CI)	P _interaction ^a
Minimally adjusted^b			.30		.20
	ALL	0.33 (0.24 to 0.39)		0.34 (0.27 to 0.42)
	HIV+ ^d	0.26 (0.15 to 0.39)^***		0.43 (0.29 to 0.59)^***
	HIV-	0.34 (0.24 to 0.44)^***		0.29 (0.19 to 0.39)^***
			.38		.12
Fully adjusted^c	ALL	0.32 (0.25 to 0.40)		0.38 (0.29 to 0.46)
	HIV+ ^d	0.28 (0.16 to 0.41)^***		0.46 (0.32 to 0.62)^***
	HIV-	0.35 (0.26 to 0.44)^***		0.31 (0.21 to 0.40)^***

Results are presented as β coefficients and 95% CIs. Interpret the coefficient as the percent increase/decrease in sICAM-1 or sVCAM-1 for every 1% increase in the biomarker of interest.

*P < .05; ^**P < .01; ^***P < .001.

^a P _interaction sICAM-1 or sVCAM-1 (HIV status and biomarker).

^bMinimally adjusted for age, sex, and HIV serostatus (for the entire population).

^cFully adjusted for age, sex, and CVD risk factors (fasting glucose levels, systolic BP, body mass index, smoking and alcohol consumption status, triglycerides, and HDL cholesterol).

^dAnalyses were further adjusted for current and nadir CD4 T-cell count and ART duration.